Mucho cuidado con esta noticia, que no digo que no sea buena pero no es oficial de la empresa ni científica. Proviene de una supuesta filtración, y su autor es un viejo conocido de los farmadictos, alias, el Bastardo.
“The best news is that most of our patients have already been discharged, which is great. We’ve only had two patients perish,” said Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the remdesivir studies for the hospital.
Her comments were made this week during a video discussion about the trial results with other University of Chicago faculty members. The discussion was recorded and STAT obtained a copy of the video."
Mullane, while encouraged by the University of Chicago data, made clear her own hesitancy about drawing too many conclusions.
“It’s always hard,” she said, because the severe trial doesn’t include a placebo group for comparison.
«Después de nada, o después de todo/ supe que todo no era más que nada.»
